SMARCA2 Deficiency While Preserving SMARCA4 and SMARCB1 in Lung Neuroendocrine Carcinomas

J Thorac Oncol. 2021 May;16(5):e32-e35. doi: 10.1016/j.jtho.2021.01.1613.

Authors

Jasna Metovic¹, Fabrizio Bianchi², Marco Barella³, Mauro Papotti¹, Giuseppe Pelosi⁴

Affiliations

¹ Department of Oncology, University of Turin, Turin, Italy.
² Cancer Biomarker Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
³ Inter-Hospital Pathology Division, IRCCS MultiMedica, Milan, Italy.
⁴ Inter-Hospital Pathology Division, IRCCS MultiMedica, Milan, Italy, Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.pelosi@unimi.it.

PMID: 33896578
DOI: 10.1016/j.jtho.2021.01.1613

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Neuroendocrine* / genetics
DNA Helicases
Humans
Lung
Lung Neoplasms* / genetics
Nuclear Proteins
SMARCB1 Protein
Transcription Factors / genetics

Substances

Nuclear Proteins
SMARCA2 protein, human
SMARCB1 Protein
SMARCB1 protein, human
Transcription Factors
SMARCA4 protein, human
DNA Helicases